Premium
Ten‐year survivors with multiple myeloma
Author(s) -
MURAKAMI H.,
NEMOTO K.,
MIYAWAKI S.,
SHIOME S.,
NOGIWA E.,
SHIMANO S.,
SATO S.,
OMINE M.,
NARUSE T.,
TSUCHIYA J.
Publication year - 1992
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/j.1365-2796.1992.tb00513.x
Subject(s) - medicine , multiple myeloma , cyclophosphamide , chemotherapy , myeloma protein , immunopathology , oncology , surgery
Of 130 Japanese patients with symptomatic multiple myeloma who were treated between 1970 and 1989, nine (6.9%) patients survived for more than 10 years. Younger age, low and intermediate tumour mass, chemotherapy with cyclophosphamide, the disappearance of myeloma protein, and a positive response to retreatment were correlated with long‐term survival.